Drug Delivery Systems for Infectious Eye Diseases: Advancements and Prospects
Journal of Nanotheranostics · 06.10.2024 · 5 (4) · 133-166
DOI: 10.3390/jnt5040010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nanotheranostics, online erschienen am 06.10.2024. Verfasst von Binapani Mahaling und 2 weiteren Autor:innen. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Infectious ocular diseases like keratitis, conjunctivitis, and endophthalmitis pose significant clinical challenges due to the complexities of delivering drugs to the eye. Recent advancements in drug delivery systems offer promising improvements for treating these conditions. Key strategies include targeted delivery through physicochemical modifications, magnetic nanoparticles, and ligand-receptor interactions. This review explores the safety and biocompatibility of ocular drug delivery systems through in vivo ocular toxicity studies, in vitro cytotoxicity assays, hemocompatibility studies, ocular tolerance tests, and genotoxicity assays. It also examines combination therapies and stimuli-responsive delivery systems for their potential to enhance therapeutic efficacy. Furthermore, we discuss tailored and optimized drug delivery approaches for infectious ocular diseases, outlining current challenges and future directions for developing effective ocular drug delivery systems.
Zitieren
APA
Mahaling, B., Baruah, N., & Dinabandhu, A. (2024). Drug Delivery Systems for Infectious Eye Diseases: Advancements and Prospects. Journal of Nanotheranostics, 5(4), 133-166. https://doi.org/10.3390/jnt5040010
Vancouver
Mahaling B, Baruah N, Dinabandhu A. Drug Delivery Systems for Infectious Eye Diseases: Advancements and Prospects. Journal of Nanotheranostics. 2024;5(4):133-166. doi:10.3390/jnt5040010
BibTeX
@article{Mahaling2024,
author = {Mahaling, Binapani and Baruah, Namrata and Dinabandhu, Aumreetam},
title = {Drug Delivery Systems for Infectious Eye Diseases: Advancements and Prospects},
journal = {Journal of Nanotheranostics},
year = {2024},
volume = {5},
number = {4},
pages = {133--166},
doi = {10.3390/jnt5040010}
}
EUVIMED